Genomenon, Inc · 17 hours ago
Remote (US) Sales Development Representative (SDR)
Maximize your interview chances
Developer ToolsEnterprise Software
Work & Life Balance
Insider Connection @Genomenon, Inc
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Work within assigned territories to identify new business by cold calling, reaching out from lists, and leveraging existing contacts.
Manages upsell and renewal opportunities within existing accounts for assigned territory.
Produce monthly, quarterly, and annual sales forecasts, plans, and budgets to support company-wide forecasting efforts.
Prospect new business within clinical territories through cold calls and existing accounts, focusing on finding growth opportunities.
Publish weekly scorecards on bookings and pipeline performance.
Organize and attend customer training sessions and sales meetings to continue building relationships with customers.
Collaborate with the account managers to develop comprehensive territory plans.
Update and maintain Salesforce CRM with accurate and current sales data.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor's degree
3+ years of sales experience
Background in genetics (i.e. genetics testing labs; as a genetic counselor)
1+ years of Salesforce CRM experience
Preferred
Experience in the bioinformatics sales industry
Master's degree or MBA
Clinical market experience
Company
Genomenon, Inc
Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer.
Funding
Current Stage
Growth StageTotal Funding
$38.23MKey Investors
BeringeaNational Institutes of HealthMichigan Angel Fund
2024-05-16Series Unknown· $5.46M
2022-03-08Series B· $20M
2022-02-15Grant· $1.7M
Recent News
GEN - Genetic Engineering and Biotechnology News
2024-12-17
2024-05-20
Company data provided by crunchbase